ALPS Advisors »

Sab Biotherapeutics shares owned by ALPS Advisors

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $303k 78k 3.90

More positions owned by ALPS Advisors

Energy Transfer Com Ut Ltd Ptn (ET)
Sunoco Lp/sunoco Fin Corp Com Ut Rep Lp (SUN)
MPLX Com Unit Rep Ltd (MPLX)
Enterprise Products Partners (EPD)
Western Midstream Partners L Com Unit Lp Int (WES)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Hess Midstream Cl A Shs (HESM)
Cheniere Energy Partners Com Unit (CQP)
Usa Compression Partners Com Unit Ltdpar (USAC)
Cameco Corporation (CCJ)
Genesis Energy Unit Ltd Partn (GEL)
Waterbridge Infrastructure L Cl A Shs Repstg (WBI)
Global Partners Com Units (GLP)
Suburban Propane Partners L Unit Ltd Partn (SPH)
Nexgen Energy (NXE)

View all positions for ALPS Advisors

Top funds holding Sab Biotherapeutics

Caligan Partners
Vivo Capital
Perceptive Advisors
Adage Capital Partners GP
RA Capital Management
Balyasny Asset Management
BlackRock
Vanguard Capital Management
Commodore Capital
Millennium Management
Spruce Street Capital
Sessa Capital IM
Affinity Asset Advisors
Boothbay Fund Management
Geode Capital Management

View all funds holding Sab Biotherapeutics